Psilocybin, the psychoactive compound in mushrooms, metabolizes into psilocin. Standard drug screenings typically do not include tests specifically designed to detect psilocin. Consequently, a routine drug test panel ordered by employers or medical facilities is unlikely to reveal prior mushroom consumption.
The absence of psilocin detection in standard drug tests stems from several factors. Psilocin has a relatively short half-life in the body, making it challenging to detect for extended periods. Moreover, the cost and complexity of developing and implementing specific psilocin assays are often deemed impractical for widespread use. Historically, drug testing has focused on substances with higher rates of abuse and societal impact, leading to the exclusion of psilocybin and psilocin.
